Search results for "Stomach"

showing 10 items of 421 documents

Multicentric randomised study of

2017

Introduction Population-based eradication of Helicobacter pylori has been suggested to be cost-effective and is recommended by international guidelines. However, the potential adverse effects of widespread antibiotic use that this would entail have not been sufficiently studied. An alternative way to decrease gastric cancer mortality is by non-invasive search for precancerous lesions, in particular gastric atrophy; pepsinogen tests are the best currently available alternative. The primary objective of GISTAR is to determine whether H pylori eradication combined with pepsinogen testing reduces mortality from gastric cancer among 40–64-year-old individuals. The secondary objectives include ev…

AdultMalePepsinogenHelicobacter InfectionsStomach NeoplasmsPepsinogen AGastroscopyProtocolHumans17241506MortalityEradicationHelicobacter pylori1695Randomised StudyPreventionStomachMiddle Aged1692Anti-Bacterial AgentsEuropeGastric CancerResearch DesignFemalePublic HealthH. Pylori1717Precancerous ConditionsBMJ open
researchProduct

Gastric outlet obstruction in a neonate because of Peutz-Jeghers syndrome

2012

Neonatal detection of Peutz-Jeghers syndrome is unusual with only 2 cases previously reported in the literature. We describe a neonate presenting with gastric outlet obstruction owing to 2 large Peutz-Jeghers polyps. The child's father and grandmother were known to have Peutz-Jeghers syndrome. On the ninth day of life, the infant underwent colonoscopy, abdominal exploration, and complete surgical resection of 3 polyps. The postoperative course was uneventful, and the patient was discharged home at the age of 3 weeks on full oral feeds. This is the first case report of inherited Peutz-Jeghers syndrome causing gastric outlet obstruction in a neonate.

AdultMalePolyhydramniosSurgical resectioncongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyDay of lifePeutz-Jeghers SyndromeColonoscopyPeutz–Jeghers syndromePolypsPregnancyStomach NeoplasmsAbdominal explorationmedicineHumansskin and connective tissue diseasesmedicine.diagnostic_testGastric Outlet Obstructionbusiness.industryInfant NewbornGastric outlet obstructionGeneral Medicinemedicine.diseasedigestive system diseasesSurgeryPediatrics Perinatology and Child HealthFemaleSurgerybusinessJournal of Pediatric Surgery
researchProduct

Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma

2000

A consecutive series of 63 untreated patients undergoing surgical resection for stage I-IV gastric adenocarcinomas (GCs) has been prospectively studied. Our purpose was to analyze the predictive relevance of DNA ploidy, S-phase fraction (SPF), and tissue levels of lysosomal proteinases cathepsin D (CD), cathepsin B (CB), cathepsin L (CL), and urokinase-type plasminogen activator (uPA) and that of the intracellular cysteine proteinase inhibitor stefin A on clinical outcome. All of the patients taking part in this study were followed up for a median of 73 months. DNA aneuploidy was present in 71% of the cases (45/63), whereas 9% of these (4/45) showed multiclonality. Both DNA ploidy and SPF w…

AdultMaleTime FactorsAdenocarcinomaS PhasePredictive Value of TestsStomach NeoplasmsBiomarkers TumorAspartic Acid EndopeptidasesHumansNeoplasm Invasivenesshumancell cycle S phase; disease association; female; histopathology; human; lymph node metastasisAgedProbabilityPloidieslymph node metastasisdisease associationSerine EndopeptidasesDNA NeoplasmMiddle AgedPrognosisSurvival AnalysisCysteine Endopeptidasescell cycle S phaseLymphatic MetastasishistopathologyFemaleFollow-Up Studies
researchProduct

Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: An Italian, multicentre study

2009

Abstract Background/Aim Data on management and long-term follow-up of Helicobacter pylori -associated MALT-lymphoma in clinical practice are scanty. We evaluate the long-term efficacy of H. pylori eradication on low-grade MALT-lymphoma, and the efficacy of further therapies in refractory patients. Methods This study enrolled patients with stages I–II 1 MALT-lymphoma and H. pylori infection. H. pylori eradication was attempted in all patients. Patients with lymphoma persistence or progression following H. pylori treatments received further lymphoma treatments. Both 5-year and disease-free survivals were calculated. Results Sixty patients (stage I/II 1 : 50/10) were followed up for a median t…

AdultMaleVincristinemedicine.medical_specialtyCyclophosphamideSettore MED/12 - GASTROENTEROLOGIAGastric maltomamanagementKaplan-Meier EstimateGastroenterologyDisease-Free SurvivalHelicobacter InfectionsYoung AdultStomach Neoplasmsimmune system diseasesPrednisonehemic and lymphatic diseasesInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansYoung adultCyclophosphamideAgedRetrospective StudiesAged 80 and overHelicobacter pyloriHepatologybiologybusiness.industryGastroenterologyProton Pump InhibitorsMALT lymphomaRetrospective cohort studyLymphoma B-Cell Marginal ZoneMiddle AgedHelicobacter pyloribiology.organism_classificationmedicine.diseaseAnti-Bacterial AgentsLymphomaSurgeryItalyDoxorubicinVincristinePrednisoneFemalebusinessFollow-Up Studiesmedicine.drug
researchProduct

Effect of the GLP-1 analog liraglutide on satiation and gastric sensorimotor function during nutrient-drink ingestion

2012

Background/Aim:Liraglutide, a glucagon-like peptide-1 analog, induces weight loss. We investigated whether liraglutide affects gastric accommodation and satiation by measuring the intragastric pressure (IGP) during nutrient-drink consumption and using the barostat technique.Methods:Ten healthy volunteers (HVs) were tested after placebo, 0.3, 0.6 or 1.2 mg liraglutide administration. IGP was studied during intragastric nutrient-drink (1.5 kcal ml(-1)) infusion (60 ml min(-1)), while the HVs scored their satiation on a graded scale until maximal satiation. In a separate session, isobaric distentions were performed using the barostat with stepwise increments of 2 mm Hg starting from minimal di…

AdultMaleendocrine systemmedicine.medical_specialtyManometryEndocrinology Diabetes and MetabolismTreatment outcomeMedicine (miscellaneous)SatiationSettore BIO/09 - FisiologiaBody Mass IndexBeveragesEatingDouble-Blind MethodGlucagon-Like Peptide 1Internal medicinegastric accomodation GLP-1 satiationPressuremedicineHumansIngestionNutrition and DieteticsDose-Response Relationship DrugLiraglutidebusiness.industryStomachdigestive oral and skin physiologyNauseaLiraglutidePostprandial PeriodTreatment OutcomeEndocrinologyGastric EmptyingFemaleGastrointestinal Motilitybusinessmedicine.drugInternational Journal of Obesity
researchProduct

Detection of precancerous gastric lesions and gastric cancer through exhaled breath.

2015

Timely detection of gastric cancer (GC) and the related precancerous lesions could provide a tool for decreasing both cancer mortality and incidence.968 breath samples were collected from 484 patients (including 99 with GC) for two different analyses. The first sample was analysed by gas chromatography linked to mass spectrometry (GCMS) while applying t test with multiple corrections (p value0.017); the second by cross-reactive nanoarrays combined with pattern recognition. For the latter, 70% of the samples were randomly selected and used in the training set while the remaining 30% constituted the validation set. The operative link on gastric intestinal metaplasia (OLGIM) assessment staging…

AdultMalemedicine.medical_specialty02 engineering and technologyGastroenterologySensitivity and Specificity03 medical and health sciences0302 clinical medicineStomach NeoplasmsInternal medicinePancreatic cancermedicineBiomarkers TumorHumansScreening toolTrial registrationEarly Detection of CancerAgedNeoplasm StagingCancer mortalityAged 80 and overVolatile Organic Compoundsbusiness.industryIncidence (epidemiology)GastroenterologyCancerGastric lesionsMiddle Aged021001 nanoscience & nanotechnologymedicine.diseaseMicroarray AnalysisBreath TestsExhalation030220 oncology & carcinogenesisFemaleNeoplasm Grading0210 nano-technologybusinessPrecancerous ConditionsGut
researchProduct

Bowel wall thickening: inquire or not inquire? Our guidelines

2018

Introduction Bowel wall thickening is not an uncommon finding among patient undergoing abdomen CT scan. It may be caused by neoplastic, inflammatory, infectious or ischaemic conditions but also be a normal variant. Although specific radiologic patterns may direct to a precise diagnosis, occasionally misidentification may occur. Thus, in the absence of guidelines, further and not always needed diagnostic procedures (colonoscopy, esophagogastroduodenoscopy or capsule endoscopy) are performed. Patients and methods We conducted a retrospective study on data collected from May 2016 to June 2017. We selected 40 adult patients, admitted in Emergency Department with "abdominal pain" and undergone a…

AdultMalemedicine.medical_specialtyAbdominal painColorectal cancerColonoscopyEndoscopy Gastrointestinallaw.inventionDiverticulitis Colonicbowel wall - CT scan03 medical and health sciencesYoung Adult0302 clinical medicineCapsule endoscopylawIschemiamedicineHumansAgedGastrointestinal NeoplasmsRetrospective StudiesAged 80 and overmedicine.diagnostic_testbusiness.industryEsophagogastroduodenoscopyStomachCancerMuscle SmoothDiverticulitisMiddle Agedmedicine.diseaseColitisEnteritisEndoscopyAbdominal PainIntestinesSettore MED/18 - Chirurgia Generale030220 oncology & carcinogenesisGastritis030211 gastroenterology & hepatologyFemaleOriginal ArticleRadiologymedicine.symptomEmergenciesbusinessTomography X-Ray Computed
researchProduct

Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3.

2010

The benefit of individualizing treatment for patients with genotype 3 HCV infection on the basis of viral clearance at week 4 (wk4-R) has not been firmly established.Four hundred and fourteen patients received Peg-interferon alpha-2b plus 1000-1200 mg of ribavirin daily according with body weightor75 kg. Patients were randomized to standard 24 weeks (Std24) or to a 12 or 36 weeks variable treatment duration (Var12/36). In the variable treatment arm, patients with or without wk4-R were allocated to either 12 or 36 weeks duration.At treatment week 4, HCV RNA was undetectable in 262 patients (63.3%), 136 in the Std24, and 126 in the Var12/36 group (p=0.41). In patients with wk4-R, end-of-treat…

AdultMalemedicine.medical_specialtyAdolescentGenotypeAlpha (ethology)Alpha interferonHepacivirusInterferon alpha-2GastroenterologyAntiviral AgentsPolyethylene Glycolschemistry.chemical_compoundYoung AdultPharmacotherapyInternal medicineGenotypeRibavirinmedicineHumansIn patientPrecision MedicineAgedHepatologybusiness.industryStomachRibavirinInterferon-alphaHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseaseRecombinant ProteinsSurgerymedicine.anatomical_structurechemistryRNA ViralFemalebusinessJournal of hepatology
researchProduct

Metabolic and psychosocial effects of minimal invasive gastric banding for morbid obesity

2003

Obesity is considered a primary risk factor for cardiovascular disease and related mortality. The current study aimed to investigate the efficacy of minimal invasive gastric banding (GB) surgery for reducing caloric intake in morbid obesity, and to analyze the effects of weight loss on body composition and metabolic and psychosocial outcomes. Twenty-six adult severely obese patients (mean body mass index [BMI], 48.1 kg/m(2); range, 42 to 56) underwent adjustable silicone laparoscopic GB. Nine additional obese patients who declined surgery were treated with metformin (2 g daily) and served as a small additional group (BMI, 50.5 kg/m(2); range, 41 to 68). Presurgery and 17 +/- 2.2 months post…

AdultMalemedicine.medical_specialtyAnemiaEndocrinology Diabetes and MetabolismBody waterImpaired glucose toleranceEndocrinologyWeight lossInternal medicineActivities of Daily LivingWeight LossmedicineHumansHypoglycemic AgentsMinimally Invasive Surgical ProceduresDigestive System Surgical ProceduresTriglyceridesAnthropometrybusiness.industryStomachMetabolic disorderHemodynamicsmedicine.diseaseObesityMetforminObesity MorbidCholesterolEndocrinologyBody CompositionQuality of LifeLean body massFemaleLaparoscopymedicine.symptombusinessBody mass indexMetabolism
researchProduct

Cryotherapy for liver metastases

2000

Cryotherapy is undergoing a renaissance in the treatment of nonresectable liver tumors. In a prospective case control study we assessed the morbidity, mortality, and efficacy of hepatic cryotherapy for liver metastases. Between January 1996 and September 1999 a total of 54 cryosurgical procedures were performed on 49 patients (median age 66 years, 21 women) with liver metastases. Patient, tumor, and operative details were recorded prospectively. Liver metastases originated from colorectal cancer (n=37), gastric cancer (n=3), renal cell carcinoma (n=2), and other primaries (n=7). Median follow-up was 13 months (1-32). The median number of liver metastases was 3 (range 1-10) with a median dia…

AdultMalemedicine.medical_specialtyColorectal cancermedicine.medical_treatmentCryotherapyCryosurgeryMetastasisStomach NeoplasmsRenal cell carcinomaInternal medicinemedicineHumansProspective StudiesAgedTumor markerbusiness.industryLiver NeoplasmsGastroenterologyCancerCryoablationMiddle AgedHepatologymedicine.diseaseSurgeryTreatment OutcomeCase-Control StudiesFemaleMorbidityNeoplasm Recurrence LocalColorectal NeoplasmsbusinessInternational Journal of Colorectal Disease
researchProduct